The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype
Open accessPublished version of a preprint
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The liver contains both NK cells and their less cytotoxic relatives, ILC1. Here, we investigate the role of NK cells and ILC1 in the obesity-associated condition, non-alcoholic fatty liver disease (NAFLD). In the livers of mice suffering from NAFLD, NK cells are less able to degranulate, express lower levels of perforin and are less able to kill cancerous target cells than those from healthy animals. This is associated with a decreased ability to kill cancer cells in vivo. On the other hand, we find that perforin-deficient mice suffer from less severe NAFLD, suggesting that this reduction in NK cell cytotoxicity may be protective in the obese liver, albeit at the cost of increased susceptibility to cancer. The decrease in cytotoxicity is associated with a shift towards a transcriptional profile characteristic of ILC1, increased expression of the ILC1-associated proteins CD200R1 and CD49a, and an altered metabolic profile mimicking that of ILC1. We show that the conversion of NK cells to this less cytotoxic phenotype is at least partially mediated by TGFβ, which is expressed at high levels in the obese liver. Finally, we show that reduced cytotoxicity is also a feature of NK cells in the livers of human NAFLD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251
Protection from obesity and diabetes by blockade of TGF-β/smad3 signaling
Yadav, H., Quijano, C., Kamaraju, A. K., Gavrilova, O., Malek, R., Chen, W., Zerfas, P., Zhigang, D., Wright, E. C., Stuelten, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.013 · Cited by 709
Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., & Gao, B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.055 · Cited by 610 · cited 1×
“NK cells can limit fibrosis in liver diseases of various etiologies by controlling the activity of hepatic stellate cells (Radaeva et al, 2006; Male et al, 2017).”
BackgroundOben, J. A., Mouralidarane, A., Samuelsson, A.-M., Matthews, P. J., Morgan, M. L., Mckee, C., Soeda, J., Fernandez-Twinn, D. S., Martin-Gronert, M. S., Ozanne, S. E., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.042 · Cited by 314
Mouralidarane, A., Soeda, J., Visconti-Pugmire, C., Samuelsson, A.-M., Pombo, J., Maragkoudaki, X., Butt, A., Saraswati, R., Novelli, M., Fusai, G., et al. (2013) · Hepatology · doi:10.1002/hep.26248 · Cited by 145
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Hart, K. M., Fabre, T., Sciurba, J. C., Gieseck, R. L., Borthwick, L. A., Vannella, K. M., Acciani, T. H., de Queiroz Prado, R., Thompson, R. W., White, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3694 · Cited by 143
Tosello‐Trampont, A., Krueger, P., Narayanan, S., Landes, S. G., Leitinger, N., & Hahn, Y. S. (2016) · Hepatology · doi:10.1002/hep.28389 · Cited by 142 · cited 2×
“In a mouse study in which a NASH-like disease was induced using a methionine and choline deficient diet, IFNγ production by NKp46+ NK cells and ILC1 protected against disease (Tosello-Trampont et al, 2016).”
BackgroundRetained NK cell phenotype and functionality in non-alcoholic fatty liver disease
Stiglund, N., Strand, K., Cornillet, M., Stål, P., Thorell, A., Zimmer, C. L., Näslund, E., Karlgren, S., Nilsson, H., Mellgren, G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01255 · Cited by 72 · cited 2×
“On the other hand, one recent study did not find a reduction in NK cell degranulation in the blood of NAFLD patients compared to controls (7).”
BackgroundResult
Research works printed but not linked: 44
- Peng, 2017, Diversity of tissue-resident NK cells, Semin Immunol, 31, 3, 10.1016/j.smim.2017.07.006 · DOI
- Peng, 2015, Re-examining the origin and function of liver-resident NK cells, Trends Immunol, 36, 293, 10.1016/j.it.2015.03.006 · DOI
- Male, 2017, Liver-resident NK cells: the human factor, Trends Immunol, 38, 307, 10.1016/j.it.2017.02.008 · DOI
- Bernink, 2013, Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues, Nat Immunol., 14, 221, 10.1038/ni.2534 · DOI · Paper page
- Forkel, 2017, Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers, Eur J Immunol., 47, 1280, 10.1002/eji.201646890 · DOI · Paper page
- Kahraman, 2010, Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis, Hepatology., 51, 92, 10.1002/hep.23253 · DOI · Paper page
- Viel, 2017, Alteration of natural killer cell phenotype and function in obese individuals, Clin Immunol., 177, 12, 10.1016/j.clim.2016.01.007 · DOI
- Tobin, 2017, NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient, JCI Insight, 2, 94939, 10.1172/jci.insight.94939 · DOI · Paper page
- Michelet, 2018, Metabolic reprogramming of natural killer cells in obesity limits antitumor responses, Nat Immunol, 19, 1330, 10.1038/s41590-018-0251-7 · DOI · Paper page
- O'Shea, 2019, Dysregulation of natural killer cells in obesity, Cancers, 11, e573, 10.3390/cancers11040573 · DOI
- Viel, 2016, TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway, Sci Signal., 9, ra19, 10.1126/scisignal.aad1884 · DOI · Paper page
- Zaiatz-Bittencourt, 2018, Canonical TGF-β signaling pathway represses human NK cell metabolism, J Immunol., 200, 3934, 10.4049/jimmunol.1701461 · DOI · Paper page
- Luci, 2019, Natural killer cells and type 1 innate lymphoid cells are new actors in non-alcoholic fatty liver disease, Front Immunol., 10, 1192, 10.3389/fimmu.2019.01192 · DOI · Paper page
- Male, 2017, Natural killer cells in liver disease, Semin Liver Dis., 37, 198, 10.1055/s-0037-1603946 · DOI
- Wensveen, 2015, NK cells link obesity-induced adipose stress to inflammation and insulin resistance, Nat Immunol, 16, 376, 10.1038/ni.3120 · DOI · Paper page
- Lee, 2016, Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity, Cell Metab., 23, 685, 10.1016/j.cmet.2016.03.002 · DOI · Paper page
- O'Rourke, 2014, Systemic NK cell ablation attenuates intra-abdominal adipose tissue macrophage infiltration in murine obesity, Obesity, 22, 2109, 10.1002/oby.20823 · DOI · Paper page
- Cepero-Donates, 2016, Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease, Cytokine., 82, 102, 10.1016/j.cyto.2016.01.020 · DOI
- Dunn, 2007, Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage, J Exp Med., 204, 667, 10.1084/jem.20061287 · DOI · Paper page
- Beraza, 2009, Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage, J Exp Med., 206, 1727, 10.1084/jem.20082152 · DOI · Paper page
- Idrissova, 2014, TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess, J Hepatol., 62, 1156, 10.1016/j.jhep.2014.11.033 · DOI · Paper page
- Hirsova, 2017, TRAIL deletion prevents liver, but not adipose tissue, inflammation during murine diet-induced obesity, Hepatol Commun., 1, 648, 10.1002/hep4.1069 · DOI · Paper page
- Fehniger, 2007, Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs, Immunity., 26, 798, 10.1016/j.immuni.2007.04.010 · DOI · Paper page
- Kärre, 1986, Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy, Nature., 319, 675, 10.1038/319675a0 · DOI · Paper page
- Hoek, 2002, Down-regulation of the macrophage lineage through interaction with OX2 (CD200), Science, 290, 1768, 10.1126/science.290.5497.1768 · DOI · Paper page
- Fernandez, 2007, CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells, J Immunol., 179, 2808, 10.4049/jimmunol.179.5.2808 · DOI
- Snelgrove, 2008, A critical function for CD200 in lung immune homeostasis and the severity of influenza infection, Nat Immunol., 9, 1074, 10.1038/ni.1637 · DOI · Paper page
- Townsend, 2004, T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells, Immunity, 20, 477, 10.1016/S1074-7613(04)00076-7 · DOI · Paper page
- Gordon, 2012, The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation, Immunity, 36, 55, 10.1016/j.immuni.2011.11.016 · DOI · Paper page
- Sciumé, 2012, Distinct requirements for T-bet in gut innate lymphoid cells, J Exp Med., 209, 2331, 10.1084/jem.20122097 · DOI · Paper page
- Klose, 2014, Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages, Cell., 157, 340, 10.1016/j.cell.2014.03.030 · DOI · Paper page
- Sojka, 2014, Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells, Elife., 3, e01659, 10.7554/eLife.01659 · DOI · Paper page
- Daussy, 2014, T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow, J Exp Med, 211, 563, 10.1084/jem.20131560 · DOI · Paper page
- Castro, 2018, The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity, Nat Immunol., 19, 809, 10.1038/s41590-018-0144-9 · DOI
- O'Brien, 2019, Immunometabolism and natural killer cell responses, Nat Rev Immunol, 19, 282, 10.1038/s41577-019-0139-2 · DOI · Paper page
- Cuff, 2016, Eomeshi NK cells in human liver are long-lived and do not recirculate but can be replenished from the circulation, J Immunol., 197, 4283, 10.4049/jimmunol.1601424 · DOI · Paper page
- Gao, 2017, Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells, Nat Immunol., 18, 1004, 10.1038/ni.3800 · DOI · Paper page
- Cortez, 2017, SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling, Nat Immunol., 18, 995, 10.1038/ni.3809 · DOI · Paper page
- O'Shea, 2010, Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke, PLoS ONE, 5, e8660, 10.1371/journal.pone.0008660 · DOI · Paper page
- Weizman, 2017, ILC1 confer early host protection at initial sites of viral infection, Cell., 171, 795, 10.1016/j.cell.2017.09.052 · DOI · Paper page
- Park, 2014, Obesity and cancer–mechanisms underlying tumour progression and recurrence, Nat Rev Endocrinol., 10, 455, 10.1038/nrendo.2014.94 · DOI · Paper page
- Cuff, 2017, Conventional NK cells and ILC1 are partially ablated in the livers of Ncr1 iCreTbx21 fl/fl mice, Wellcome Open Res., 2, 39, 10.12688/wellcomeopenres.11741.1 · doi:10.12688/wellcomeopenres.11741.1
- Varet, 2016, SARTools: a DESeq2- and EdgeR-based R pipeline for comprehensive differential analysis of RNA-Seq Data, PLoS ONE, 11, e0157022, 10.1371/journal.pone.0157022 · DOI · Paper page
- Cuff, 2019, TGFβ in the obese liver mediates conversion of NK cells to a less cytotoxic ILC1-like phenotype, bioRxiv., 10.1101/576538 · DOI · Paper page
Cited by
Plasticity of innate lymphoid cell subsets
Bal, S. M., Golebski, K., & Spits, H. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0282-9 · Cited by 304
Luci, C., Bourinet, M., Leclère, P. S., Anty, R., & Gual, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.597648 · Cited by 195
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
Sawada, K., Chung, H., Softic, S., Moreno-Fernandez, M. E., & Divanovic, S. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.009 · Cited by 139
Hepatic Stellate Cell-Immune Interactions in NASH
Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79
“In a murine NAFLD model, increased TGFb signaling led to loss of NK cell cytolytic activity – potentially an adaptive mechanism to reduce liver inflammation (114).”
BackgroundNAFLD and HBV interplay - related mechanisms underlying liver disease progression
Tourkochristou, E., Assimakopoulos, S. F., Thomopoulos, K., Marangos, M., & Triantos, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.965548 · Cited by 70
Metadata
- Authors
- Cuff, A. O., Sillito, F., Dertschnig, S., Hall, A., Luong, T. V., Chakraverty, R., & Male, V.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-09-11
- Volume
- 10
- Pages
- 2180-2180
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2970108200
- Cited by
- 102
- References
- 9
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Wellcome Trust (WT105677)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype. https://app.cochat.ai/papers/10.3389/fimmu.2019.02180
- The paper
- Cuff, A. O., Sillito, F., Dertschnig, S., Hall, A., Luong, T. V., Chakraverty, R., & Male, V. (2019). The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2019.02180
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.